BiochemProbe — Life Science Research Reagents

BRD-810 free base · Synonyms: BRD 810 · BRD810

BRD-810 is a highly selective MCL1 inhibitor.

For research use only. Not for human or veterinary use.

Research area Cancer
Purity >98% Stock Inquire

BRD-810 structure

CAS No.: 2329719-65-3

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
1 mg USD 498.00 BP-01119-1mg In stock Get quote
5 mg USD 1,150.00 BP-01119-5mg In stock Get quote
10 mg USD 1,850.00 BP-01119-10mg In stock Get quote
25 mg USD 2,850.00 BP-01119-25mg In stock Get quote
50 mg Inquire BP-01119-50mg In stock Inquire
100 mg Inquire BP-01119-100mg In stock Inquire

Need another size or custom synthesis? Request a quote.

Description

BRD-810 is a highly selective MCL1 inhibitor. BRD-810 shows anti-tumor activity in models of blood cancers and solid tumors.

Biological activity

BRD-810 is a highly selective MCL1 inhibitor. BRD-810 can bind to the BH3 groove of MCL1 and block the sequestration of pro-apoptotic proteins, quickly inducing caspase activation in MCL1-dependent cell lines. BRD-810 shows anti-tumor activity in models of blood cancers and solid tumors.

Identifiers

SMILES
ClC1=C2C3=C(C(CCCOC=4C5=C(C=CC4)C=C(F)C=C5)=C(C(O)=O)N3CCCCO[C@H](CCN6CCOCC6)C=7C2=C(CC)N(C)N7)C=C1
InChIKey
RQXSLNDYCDRXAC-MGBGTMOVSA-N

Specifications

MW (average)
703.2420
Formula
C39H44ClFN4O5
CAS No.
2329719-65-3
Physical state
Solid
Color
white to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 3 years; 4℃ 2 years; protect from light; In solvent -20℃ 1 month;

Solubility

soluble in DMSO:

In vitro
DMSO : 100 mg/mL

References

[1]. Rauh U, et al. BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models. Nat Cancer. 2024 Oct;5(10):1479-1493.

Same target

Search Bcl-2 Family

Same research area

Search Cancer